Rajat Bhattacharya

Publication Activity (10 Years)

Years Active: 2022-2023
Publications (10 Years): 7

Top Topics

Metastatic Colorectal Cancer

Top Venues

Molecular cancer research : MCR

Molecular cancer therapeutics

This page only lists publications with an associated author ORCID identifier.

Publications

Susmita Ghosh, Fan Fan, Reid T Powell, Jason Roszik, Yongsung Park, Clifford Stephen, Manu Sebastian, Lin Tan, Alexey V Sorokin, Philip L Lorenzi, Edmund S Kopetz, Lee M Ellis, Rajat Bhattacharya
Vincristine Enhances the Efficacy of MEK Inhibitors in Preclinical Models of KRAS-mutant Colorectal Cancer. Molecular cancer therapeutics (2023)
Fan Fan, Susmita Ghosh, Reid Powell, Jason Roszik, Yongsun Park, Mary Sobieski, Alexey Sorokin, Clifford Stephen, Scott Kopetz, Lee M Ellis, Rajat Bhattacharya
Combining MEK and SRC inhibitors for treatment of colorectal cancer demonstrate increased efficacy in vitro but not in vivo. PloS one 18 (3) (2023)
Chandrani Chattopadhyay, Rajat Bhattacharya, Jason Roszik, Fatima S Khan, Gabrielle A Wells, Hugo Villanueva, Yong Qin, Rishav Bhattacharya, Sapna Pradyuman Patel, Elizabeth A Grimm
Targeting IRS-1/2 in Uveal Melanoma Inhibits In Vitro Cell Growth, Survival and Migration, and In Vivo Tumor Growth. Cancers 14 (24) (2022)
Moeez Rathore, Wei Zhang, Michel'le Wright, Rajat Bhattacharya, Fan Fan, Ali Vaziri-Gohar, Jordan Winter, Zhenghe Wang, Sanford D Markowitz, Joseph Willis, Lee M Ellis, Rui Wang
Liver Endothelium Promotes HER3-Mediated Cell Survival in Colorectal Cancer with Wild-Type and Mutant KRAS. Molecular cancer research : MCR 20 (6) (2022)
Fan Fan, Jason Roszik, Ling Xia, Susmita Ghosh, Rui Wang, Xiangcang Ye, David Hawke, Lee M Ellis, Rajat Bhattacharya
Cytospin-A Regulates Colorectal Cancer Cell Division and Migration by Modulating Stability of Microtubules and Actin Filaments. Cancers 14 (8) (2022)
Chandrani Chattopadhyay, Rajat Bhattacharya, Jason Roszik, Fatima S Khan, Gabrielle A Wells, Hugo Villanueva, Yong Qin, Rishav Bhattacharya, Sapna Pradyuman Patel, Elizabeth A Grimm
Targeting IRS-1/2 in Uveal Melanoma Inhibits In Vitro Cell Growth, Survival and Migration, and In Vivo Tumor Growth. Cancers 14 (24) (2022)
Chandrani Chattopadhyay, Rajat Bhattacharya, Jason Roszik, Fatima S Khan, Gabrielle A Wells, Hugo Villanueva, Yong Qin, Rishav Bhattacharya, Sapna Pradyuman Patel, Elizabeth A Grimm
Targeting IRS-1/2 in Uveal Melanoma Inhibits In Vitro Cell Growth, Survival and Migration, and In Vivo Tumor Growth. Cancers 14 (24) (2022)